Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug shortage
Pharma
FDA removes Lilly's Mounjaro and Zepbound from its shortage list
Eli Lilly’s tirzepatide has been erased from the FDA’s shortage list, freeing Lilly from competing with compounders that have been making copycats.
Kevin Dunleavy
Oct 3, 2024 11:22am
Theratechnologies' HIV med may run short due to contractor issue
Sep 18, 2024 12:11pm
Coherus' Udenyca in short supply thanks to contractor flub
Sep 17, 2024 2:25pm
Astellas, AstraZeneca, Glenmark and more—Fierce Pharma Asia
Sep 6, 2024 9:00am
Shortages of Novo Nordisk's Ozempic to persist into Q4
Sep 3, 2024 11:14am
Low costs for generics a driving force behind shortages: report
Jul 22, 2024 3:56pm
